IGENOMIX - Pioneers in Reproductive Genetics

Igenomix at ASRM 2022

Thank you for joining Igenomix and Vitrolife at this year’s ASRM 2022 Scientific Congress & Expo in Anaheim, California. We hope you had the opportunity to learn more about our innovative new research and attend one of our LIVE studio sessions. If you were unable to join us, click on the button below for access to our studio sessions and more.

Click Here for Igenomix at ASRM

Endometrial microbiota is associated with reproductive outcome in infertile patient

New study led by Dr. Inmaculada Moreno shows that endometrial microbiota composition before embryo transfer is an useful biomarker to predict reproductive outcome, offering an opportunity to further improve diagnosis and treatments strategies

Learn more!

Vitrolife completes THE acquisition of Igenomix

Together, we create a global leader in reproductive health

It is with great pleasure that we can communicate Vitrolife AB has concluded the acquisition of Igenomix. The two separate companies will continue operating independently but, by combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, we will be able to better support clinics and patients across the fertility journey.

Visit Vitrolife website

Vitrolife completes the acquisition of Igenomix

Together, we create a global leader in reproductive health

It is with great pleasure that we can communicate Vitrolife AB has concluded the acquisition of Igenomix. The two separate companies will continue operating independently but, by combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, we will be able to better support clinics and patients across the fertility journey

Visit Vitrolife website

+6
PATENTS

460
SCIENTIFIC
PUBLICATIONS

++550
PROFESSIONALS

26
LABS
WORLDWIDE

Genetic Solutions for Specialists

Igenomix offers pioneering tests to help reproductive health professionals diagnose and treat their patients.

Preconception

Detect genetic changes in the egg source or sperm source before conception so you can explore about options to have a healthy baby

More information

Preimplantation

Help reduce the risk for implantation failure or miscarriage and improve the chances for a healthy pregnancy

More information

Prenatal

Understand whether a pregnancy is at an increased risk for a genetic syndrome

More information

See all services

We will guide you

Fertility

Educational content whatever is your reproductive journey

More information

Healthy Pregnancy

Avoid a miscarriage or an implantation failure

More information

Your Baby

Maximize your chances during an IVF treatment

More information

See all services

Igenomix Research

Igenomix Development

We actively works in research the most advanced techniques to reproductive genetics.

Igenomix Research

Providing solutions to professionals working in reproductive medicine

About Igenomix

We work to make a world in which infertility is no longer an impossible barrier. Together with clinics and fertility doctors worldwide, we investigate human reproduction to change the lives of couples who are trying to conceive.

Learn more about Igenomix

Corporate news

More news

Igenomix at ASRM 2022

2022 PGT-A Webinar Series

Endometrial microbiota is associated with reproductive outcome in infertile patient

New study led by Dr. Inmaculada Moreno shows that endometrial microbiota composition before embryo transfer is an useful biomarker to predict reproductive outcome, offering an opportunity to further improve diagnosis and treatments strategies

Vitrolife completes THE acquisition of Igenomix

Together, we create a global leader in reproductive health

Vitrolife completes the acquisition of Igenomix

Together, we create a global leader in reproductive health

Genetic Solutions for Specialists

Preconception

Preimplantation

Prenatal

We will guide you

Fertility

Healthy Pregnancy

Your Baby

Igenomix Research

Igenomix Development

Igenomix Research

About Igenomix

Corporate news

Prof. Simon joins the debate about mosaicism in The Wall Street Journal